Pierre Foskett
Papers
1
Total Citations
15
H-Index
1
About
Pierre Foskett has made significant contributions to the field of molecular monitoring in hematological malignancies, with a primary focus on improving the accuracy and efficiency of BCR-ABL1 detection. His most cited work, "Fast‐mode duplex qPCR for BCR-ABL1 molecular monitoring: Innovation, automation, and harmonization" (2012, 15 citations), addresses the critical need for standardized, high-throughput methods in routine clinical diagnostics. Foskett’s research centers on advancing reverse transcription quantitative polymerase chain reaction (RT-qPCR) techniques, which remain the gold standard for sensitive disease surveillance in patients with chronic myeloid leukemia and other BCR-ABL1-associated disorders. His contributions emphasize innovation in duplex qPCR design, automation to reduce human error, and harmonization across laboratories to ensure reproducible results. By tackling both local and international challenges in assay standardization, Foskett’s work has helped bridge the gap between research and clinical application, ultimately improving patient monitoring and treatment outcomes. His dedication to refining molecular tools underscores his impact on precision oncology and laboratory medicine.
Research Focus
Key Achievements
Top Papers
- 1